Anti-Infectives Partnering & Deal-Making 2017

The 14th Anti-Infectives Partnering & Deal-Making Conference, which will take place July 13-14, 2017 in Baltimore, MD. Recently launched programs such as CARB-X and the expanded pool of research and development funds brought about by the U.S. National Action Plans on Combating Antibiotic Resistant Bacteria (CARB) demonstrate recognition that the anti-infective pipeline is precariously fragile. These complimentary programs, as well as other international programs, seek to address funding and market limitations that occur at all phases of drug development, from early stage, hit to lead identification, to late stage clinical development. However, despite the technical and monetary resources available to developers the challenges and risks inherent in anti-infective development loom unabated.